Xeris Pharmaceuticals Secures $41,000,000 Series C Funding Round

  • Feed Type
  • Date
    1/12/2016
  • Company Name
    Xeris Pharmaceuticals
  • Mailing Address
    3208 Red River Street Austin, TX 78705 USA
  • Company Description
    Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology.
  • Website
    http://www.xerispharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $41,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Redmile Group
  • Venture Investor
    Deerfield Capital
  • Venture Investor
    Sabby Capital
  • Venture Investor
    McNair Group

Trending on Xconomy